Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
CMS Slashes Prices Of 15 Major Drugs - Here's Why Pharma Valuations Won't Suffer
The U.S. government has announced significant Medicare drug price cuts affecting 15 major drugs, with Novo Nordisk appearing most impacted by the latest round. Despite headline-grabbing price reductions, the Pharma sector remains resilient, with…
Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies
Shelby Knowles | Bloomberg | Getty Images The IRA from 2022 allows the CMS to negotiate prices for a number of drugs each year for patients in Medicare. Late Tuesday, the agency announced newly negotiated prices for 15 blockbuster drugs from 2027…
Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M
HERZLIYA, Israel and CALGARY, AB, Nov. 27, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the 'Company' or 'Innocan'), a pharmaceutical technology company focusing on developing innovative drug delivery platform…
Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities
Piramal Pharma Solutions implemented a robust action plan to address evolving regulatory requirements pertaining to nitrosamine impurities. Through comprehensive risk assessments, confirmatory testing, and control strategies, the Company is…
Is the Market Bullish or Bearish on Ascendis Pharma AS? - Ascendis Pharma (NASDAQ:ASND)
Ascendis Pharma AS's (NYSE:) short interest as a percent of float has risen 3.68% since its last report. According to exchange reported data, there are now 3.55 million shares sold short, which is 7.05% of all regular shares that are available for…
Data exclusivity will extend pharma monopolies, delay access to affordable medicines, activists say
As the Central Drugs Standard Control Organisation (CDSCO) considers introducing data exclusivity provisions into India's drug regulatory laws, healthcare activists warned that the move could delay access to lifesaving generic drugs, reduce the…
Stock to buy today: Natco Pharma (₹926.90) - BUY
The short-term outlook is bullish for Natco Pharma. The stock had surged over 11 per cent on Wednesday thereby making a breakout and a decisive close ₹900, a key resistance. Strong support is now in the ₹900-880 region. This can limit…
SMS Pharma gains 18% on U.S FDA nod for reformulated Ranitidine of associate firm
SMS Pharmaceuticals shares gained nearly 18% on the back of U.S. Food and Drug Administration approving associate company VKT Pharma's reformulated Ranitidine. The approval also marks the re-entry of the important acid-reducing medication into the…
Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market
AHMEDABAD, India and NEW YORK, Nov. 26, 2025 /CNW/ -- Zydus Lifesciences Ltd. (including its subsidiaries and affiliates), a global innovation-driven healthcare company, today announced that it has entered into an exclusive licensing and…
Stock Market live updates 27th Nov 2025: Stock to buy today: Natco Pharma (₹926.90) - BUY
Stock Market today | Share Market Highlights- Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 27th Nov 2025 Published on November 27, 2025 01:28…
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Rating of 'Moderate Buy' by Analysts
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) have received an average rating of 'Moderate Buy' from the twenty-one ratings firms that are currently covering the firm, Marketbeat reports. One investment analyst has rated the…
12 Health Care Stocks Moving In Wednesday's Intraday Session - Bruker (NASDAQ:BRKRP), Arrowhead Pharma (NASDAQ:ARWR)
Pasithea Therapeutics (NASDAQ:) shares moved upwards by 99.8% to $0.97 during Wednesday's regular session. The company's market cap stands at $3.6 million. Zynex (NASDAQ:) shares increased by 64.15% to $1.21. The company's market cap stands at…
Ascendis Pharma A/S $ASND Shares Sold by KBC Group NV
KBC Group NV reduced its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 99.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 356 shares of the…
Swiss National Bank Purchases 50,100 Shares of Royalty Pharma PLC $RPRX
Swiss National Bank boosted its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 4.7% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,115,200 shares…
Pharma: AI Rally Is Real - And Cancer May Soon Be Chronic, Not Deadly - iShares Biotechnology ETF (NASDAQ:IBB), Tema Oncology ETF (NASDAQ:CANC)
Pharma stocks have recently emerged as one of Wall Street's hottest trades, with November marking a striking inflection point few had expected. In an exclusive interview with Benzinga on Wednesday, Tema ETFs founder and CEO Maurits Pot said the…
Receive a Daily briefing on Pharma Industry News
Get Started